Cargando…
SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study
SARS-CoV-2 is a worldwide challenge for the medical sector. Healthcare workers (HCW) are a cohort vulnerable to SARS-CoV-2 infection due to frequent and close contact with COVID-19 patients. However, they are also well trained and equipped with protective gear. The SARS-CoV-2 IgG antibody status was...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123190/ https://www.ncbi.nlm.nih.gov/pubmed/33922895 http://dx.doi.org/10.3390/ijerph18094540 |
_version_ | 1783692831115706368 |
---|---|
author | Korth, Johannes Wilde, Benjamin Dolff, Sebastian Frisch, Jasmin Jahn, Michael Krawczyk, Adalbert Trilling, Mirko Schipper, Leonie Cordes, Sebastian Ross, Birgit Lindemann, Monika Kribben, Andreas Dittmer, Ulf Witzke, Oliver Herrmann, Anke Anastasiou, Olympia Evdoxia |
author_facet | Korth, Johannes Wilde, Benjamin Dolff, Sebastian Frisch, Jasmin Jahn, Michael Krawczyk, Adalbert Trilling, Mirko Schipper, Leonie Cordes, Sebastian Ross, Birgit Lindemann, Monika Kribben, Andreas Dittmer, Ulf Witzke, Oliver Herrmann, Anke Anastasiou, Olympia Evdoxia |
author_sort | Korth, Johannes |
collection | PubMed |
description | SARS-CoV-2 is a worldwide challenge for the medical sector. Healthcare workers (HCW) are a cohort vulnerable to SARS-CoV-2 infection due to frequent and close contact with COVID-19 patients. However, they are also well trained and equipped with protective gear. The SARS-CoV-2 IgG antibody status was assessed at three different time points in 450 HCW of the University Hospital Essen in Germany. HCW were stratified according to contact frequencies with COVID-19 patients in (I) a high-risk group with daily contacts with known COVID-19 patients (n = 338), (II) an intermediate-risk group with daily contacts with non-COVID-19 patients (n = 78), and (III) a low-risk group without patient contacts (n = 34). The overall seroprevalence increased from 2.2% in March–May to 4.0% in June–July to 5.1% in October–December. The SARS-CoV-2 IgG detection rate was not significantly different between the high-risk group (1.8%; 3.8%; 5.5%), the intermediate-risk group (5.1%; 6.3%; 6.1%), and the low-risk group (0%, 0%, 0%). The overall SARS-CoV-2 seroprevalence remained low in HCW in western Germany one year after the outbreak of COVID-19 in Germany, and hygiene standards seemed to be effective in preventing patient-to-staff virus transmission. |
format | Online Article Text |
id | pubmed-8123190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81231902021-05-16 SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study Korth, Johannes Wilde, Benjamin Dolff, Sebastian Frisch, Jasmin Jahn, Michael Krawczyk, Adalbert Trilling, Mirko Schipper, Leonie Cordes, Sebastian Ross, Birgit Lindemann, Monika Kribben, Andreas Dittmer, Ulf Witzke, Oliver Herrmann, Anke Anastasiou, Olympia Evdoxia Int J Environ Res Public Health Article SARS-CoV-2 is a worldwide challenge for the medical sector. Healthcare workers (HCW) are a cohort vulnerable to SARS-CoV-2 infection due to frequent and close contact with COVID-19 patients. However, they are also well trained and equipped with protective gear. The SARS-CoV-2 IgG antibody status was assessed at three different time points in 450 HCW of the University Hospital Essen in Germany. HCW were stratified according to contact frequencies with COVID-19 patients in (I) a high-risk group with daily contacts with known COVID-19 patients (n = 338), (II) an intermediate-risk group with daily contacts with non-COVID-19 patients (n = 78), and (III) a low-risk group without patient contacts (n = 34). The overall seroprevalence increased from 2.2% in March–May to 4.0% in June–July to 5.1% in October–December. The SARS-CoV-2 IgG detection rate was not significantly different between the high-risk group (1.8%; 3.8%; 5.5%), the intermediate-risk group (5.1%; 6.3%; 6.1%), and the low-risk group (0%, 0%, 0%). The overall SARS-CoV-2 seroprevalence remained low in HCW in western Germany one year after the outbreak of COVID-19 in Germany, and hygiene standards seemed to be effective in preventing patient-to-staff virus transmission. MDPI 2021-04-25 /pmc/articles/PMC8123190/ /pubmed/33922895 http://dx.doi.org/10.3390/ijerph18094540 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Korth, Johannes Wilde, Benjamin Dolff, Sebastian Frisch, Jasmin Jahn, Michael Krawczyk, Adalbert Trilling, Mirko Schipper, Leonie Cordes, Sebastian Ross, Birgit Lindemann, Monika Kribben, Andreas Dittmer, Ulf Witzke, Oliver Herrmann, Anke Anastasiou, Olympia Evdoxia SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study |
title | SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study |
title_full | SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study |
title_fullStr | SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study |
title_full_unstemmed | SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study |
title_short | SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study |
title_sort | sars-cov-2 seroprevalence in healthcare workers in germany: a follow-up study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123190/ https://www.ncbi.nlm.nih.gov/pubmed/33922895 http://dx.doi.org/10.3390/ijerph18094540 |
work_keys_str_mv | AT korthjohannes sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT wildebenjamin sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT dolffsebastian sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT frischjasmin sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT jahnmichael sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT krawczykadalbert sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT trillingmirko sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT schipperleonie sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT cordessebastian sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT rossbirgit sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT lindemannmonika sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT kribbenandreas sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT dittmerulf sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT witzkeoliver sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT herrmannanke sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy AT anastasiouolympiaevdoxia sarscov2seroprevalenceinhealthcareworkersingermanyafollowupstudy |